VNIM
TMO icon

Vaughan Nelson Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Vaughan Nelson Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-235
Closed -$134K – 256
2021
Q3 		$134K Buy
+235
New +$129K ﹤0.01% 191
2021
Q1 		– Sell
-165,422
Closed -$77.1M – 187
2020
Q4 		$77.1M Sell
165,422
-95,853
-37% -$44.9M 0.9% 38
2020
Q3 		$115M Sell
261,275
-79,549
-23% -$32.9M 1.61% 13
2020
Q2 		$123M Sell
340,824
-10,170
-3% -$3.41M 1.77% 13
2020
Q1 		$99.5M Buy
350,994
+3,400
+1% +$1.07M 1.7% 9
2019
Q4 		$113M Buy
347,594
+2,540
+0.7% +$770K 1.41% 15
2019
Q3 		$101M Sell
345,054
-655
-0.2% -$188K 1.34% 16
2019
Q2 		$102M Buy
345,709
+29,310
+9% +$8.07M 1.35% 18
2019
Q1 		$86.6M Buy
316,399
+3,777
+1% +$940K 1.16% 19
2018
Q4 		$70M Buy
312,622
+36,520
+13% +$8.57M 1% 25
2018
Q3 		$67.4M Buy
276,102
+15,730
+6% +$3.62M 0.79% 35
2018
Q2 		$53.9M Buy
260,372
+16,158
+7% +$3.43M 0.64% 60
2018
Q1 		$50.4M Sell
244,214
-1,355
-0.6% -$284K 0.62% 67
2017
Q4 		$46.6M Buy
245,569
+6,216
+3% +$1.19M 0.54% 84
2017
Q3 		$45.3M Sell
239,353
-55,576
-19% -$10.1M 0.54% 81
2017
Q2 		$51.5M Buy
294,929
+3,810
+1% +$640K 0.62% 67
2017
Q1 		$44.7M Sell
291,119
-8,310
-3% -$1.27M 0.53% 89
2016
Q4 		$42.3M Sell
299,429
-6,006
-2% -$885K 0.5% 95
2016
Q3 		$48.6M Sell
305,435
-102,855
-25% -$15.8M 0.58% 74
2016
Q2 		$60.3M Sell
408,290
-113,270
-22% -$16.7M 0.76% 47
2016
Q1 		$73.8M Buy
521,560
+68,785
+15% +$9.22M 0.93% 33
2015
Q4 		$64.2M Sell
452,775
-33,625
-7% -$4.48M 0.82% 44
2015
Q3 		$59.5M Buy
486,400
+3,375
+0.7% +$440K 0.85% 39
2015
Q2 		$62.7M Buy
483,025
+64,591
+15% +$8.42M 0.88% 42
2015
Q1 		$56.2M Buy
+418,434
New +$53.9M 0.86% 49

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vaughan Nelson Investment Management's TMO Position: Q4 2021 in Review

Vaughan Nelson Investment Management sold out of Thermo Fisher Scientific (TMO) in Q4 2021, closing a stake of 235 shares — an estimated $134K sold.

Vaughan Nelson Investment Management first reported a position in TMO in Q1 2015 and held it in 25 quarters. The position peaked at $123M in Q2 2020. 2,342 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

  • Vaughan Nelson Investment Management reported no remaining Thermo Fisher Scientific position as of Q4 2021 after selling out during the quarter.
  • Vaughan Nelson Investment Management sold 235 Thermo Fisher Scientific shares in Q4 2021, an estimated $134K.
  • Vaughan Nelson Investment Management first reported a position in Thermo Fisher Scientific in Q1 2015 and held it in 25 quarters.
  • Vaughan Nelson Investment Management's Thermo Fisher Scientific position peaked at $123M in Q2 2020.
  • 2,342 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Vaughan Nelson Investment Management's 13F filing for Q4 2021, filed 13 Jan 2022.